ESCRS - Celebrating Charles Kelman and phacoemulsification.

Celebrating Charles Kelman and phacoemulsification.

Dr. Robert Osher introduces this tribute video to Dr. Charles Kelman, originally shown in 2004 after he had passed away.

Celebrating Charles Kelman and phacoemulsification.
Colin Kerr
Colin Kerr
Published: Friday, June 23, 2017
Dr. Robert Osher introduces this tribute video to Dr. Charles Kelman, originally shown in 2004 after he had passed away. The video documents his huge contribution to ophthalmology and celebrates his remarkable life and career. Highlights include: -Early phacoemulsification teaching footage -Some of the first ever ophthalmic live surgeries -His appearances on Late-Night Talk Shows including David Letterman and Johnny Carson -Several high-profile lectures he gave over the years http://player.escrs.org/…/celebrating-charles-kellman-on-th…
Latest Articles
Simulators Benefit Surgeons and Patients

Helping young surgeons build confidence and expertise.

Read more...

Diamonds in the Rough

The push for inclusivity in ophthalmology.

Read more...

Making Female Leadership More than a Moment

A remarkable global confluence of women in key positions.

Read more...

ESCRS Talks Technology at AAO

Europe adopts technological advances, US still waiting for lenses and lasers.

Read more...

Sorting Out Simultaneous Vision IOLs

The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.

Read more...

Big Advantages to Small-Aperture IOLs

Small-aperture IOLs offer superior image quality with increased range of focus.

Read more...

Prioritising Self-Care

Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.

Read more...

Valuing Clinical Trial Design

How inclusivity and diversity can enhance scientific accuracy in research.

Read more...

Knowing Iris Repair: Using Iridodiathermy in Iris Surgery

Prepare for decentred pupils and uneven irides in multiple situations.

Read more...

Neuroprotectant Treatment for MacTel Type 2

Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.

Read more...